The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary (2002)
Chapter: Appendix IV: Workshop Agenda
Appendix IV
Workshop Agenda
DECEMBER 12, 2001
Park Hyatt Hotel, Washington, DC
Park Hyatt Ballroom
|
8:30 am |
Welcoming Remarks and Meeting Objectives |
|
|
Clinical Research Roundtable Co-Chairs |
|
|
Enriqueta Bond, Ph.D. President Burroughs Welcome Fund |
|
|
William Gerberding, Ph.D. President Emeritus University of Washington |
|
|
Workshop Co-Chairs |
|
|
Allan Korn, M.D. Senior Vice President and Chief Medical Officer Blue Cross Blue Shield Association |
|
|
Sean Tunis, M.D., M.Sc. Director, Coverage and Analysis Group Office of Clinical Standards and Quality Centers for Medicare and Medicaid Services |
|
9:00 |
Purchaser Perspective |
|
|
Each speaker has been asked to present a brief 5 min. overview of their responses to the two broad questions. |
|
|
Moderator—Patricia Salber MD, General Motors |
Jill Berger
Corporate Health and Welfare
Manager
Marriot
Helen Darling
President
Washington Business Group on
Health
Bruce Taylor
Director National Health Care &
Policy Plans
Verizon
Dale Whitney
Corporate Health and Welfare
Manager
United Parcel Service
Gregg Lehman
President & CEO
National Business Coalition on
Health
Jon Hautz
Senior Consultant
William M. Mercer Inc.
|
9:30 |
Clinical Research Roundtable Discussion |
|
10:15 |
Questions and Comments from the Audience |
|
10:30 |
Break |
|
10:45 |
Payer & Health System Perspective |
|
|
Each speaker has been asked to present a brief 5 min. overview of their responses to the two broad questions. |
|
|
Moderators—Alan Korn, Blue Cross Blue Shield Association and Sean Tunis, Centers for Medicare and Medicaid Services |
Eric Book, MD
Chief Medical Officer
Wellmark
Reed Tuckson, MD
Chief Medical Officer
United Healthgroup
Robert McDonough, MD
Medical Director for Quality Management
Aetna
George Isham, MD
Medical Director and Chief Health Officer
HealthPartners
Chuck Cutler, MD
Chief Medical Officer
American Association of Health Plans
|
11:15 |
Clinical Research Roundtable Discussion |
|
12:00 |
Questions and Comments from the Audience |
|
12:15 pm |
Lunch (for members and guests in the meeting room) |
|
1:15 |
Stakeholder Perspective |
|
|
Please respond to the issues raised in the first two panels. What are your needs? What is your role? What can you contribute to the Clinical Research Enterprise? |
|
|
Moderator—Myrl Weinberg, President, National Health Council |
Francis Chesley, MD
Director, Office of Research,
Review, Education and Policy
Agency for Healthcare, Research & Quality
Susan Foote, JD
Board Member, Medical Technology
Leadership Forum
Dennis Scanlon, Ph.D.
Associate Professor, Health Policy and Administration
Pennsylvania State University
Robert M. Califf, MD
Division of Cardiology, Department of Medicine
Duke University
John H. Graham IV
Chief Executive Officer
American Diabetes Association
John Stevens, MD
Vice President for Extramural Grants
Research Department
American Cancer Society
|
1:45 |
Clinical Research Roundtable Discussion |
|
2:30 |
Questions and Comments from the Audience |
|
2:45 |
Break |
|
3:00 |
Roundtable Discussion: Opportunities and challenges |
|
|
This two-hour discussion regarding opportunities and challenges for the Clinical Research Enterprise will begin with a 20-minute presentation by Dr. Lou Sherwood. Audience participation is wel come. |
|
|
Moderators—Allan Korn, BCBSA and Sean Tunis, CMS |
|
|
“The Second Frontier” – Lou Sherwood, M.D. Senior Vice President for Medical and Scientific Affairs Merck and Company |
|
5:00 |
Concluding Remarks |
|
|
Enriqueta Bond, Ph.D. President Burroughs-Welcome Fund |
|
|
William Gerberding, Ph.D. President Emeritus University of Washington |
